Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Crizotinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 6,826Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pfizer's LORBRENA Showed 5+ Year PFS In ALK+ Lung Cancer CROWN Study
    Pfizer's LORBRENA Showed 5+ Year PFS In ALK+ Lung Cancer CROWN Study

    01 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240530259641/en

    BUSINESSWIRE
    01 Jun 2024
    Share Share
    IDEAYA Biosciences Announces Proffered Paper Oral Presentation at ESMO 2023
    IDEAYA Biosciences Announces Proffered Paper Oral Presentation at ESMO 2023

    17 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ideaya-biosciences-announces-proffered-paper-oral-presentation-at-esmo-2023-for-phase-2-clinical-data-update-for-darovasertib-and-crizotinib-combination-in-metastatic-uveal-melanoma-301958315.html

    PR NEWSWIRE
    17 Oct 2023
    Share Share
    IDEAYA Biosciences Announces Phase 2 Expansion of Darovasertib and Crizotinib
    IDEAYA Biosciences Announces Phase 2 Expansion of Darovasertib and Crizotinib

    16 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ideaya-biosciences-announces-phase-2-expansion-of-darovasertib-and-crizotinib-combination-in-gnaq11-metastatic-cutaneous-melanoma-301956860.html

    PR NEWSWIRE
    16 Oct 2023
    Share Share
    PF Prism's Generic Xalkori, Crizotinib Receives Approval in the U.S.
    PF Prism's Generic Xalkori, Crizotinib Receives Approval in the U.S.

    07 Sep 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217581

    FDA
    07 Sep 2023
    Share Share
    IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer
    IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer

    16 May 2023

    // PRESS RELEASE

    https://media.ideayabio.com/2023-05-16-IDEAYA-Expands-Clinical-Trial-Collaboration-and-Supply-Agreements-with-Pfizer-to-Support-Registrational-Trial-Evaluating-Darovasertib-and-Crizotinib-Combination-in-First-Line-Metastatic-Uveal-Melanoma

    PRESS RELEASE
    16 May 2023
    Share Share
    Pharma companies boost drug prices to start year, but hikes lag inflation
    Pharma companies boost drug prices to start year, but hikes lag inflation

    04 Jan 2023

    // Jonathan Gardner BIOPHARMADIVE

    https://www.biopharmadive.com/news/pharma-drug-price-increases-january-new-year/639564/

    Jonathan Gardner BIOPHARMADIVE
    04 Jan 2023
    Share Share